23 Einträge gefunden

1. Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers.

   1. Marx, Andreas
   2. Burandt, Eike Christian
   3. Choschzick, Matthias
   4. Simon, Ronald
   5. Yekebas, Emre F.
   6. Kaifi, Jussuf
   7. Mirlacher, Martina

   2010 - Forschungsinformationssystem des UKE
2. Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma: long-term follow-up.

   1. Shimoni, Avichai
   2. Hardan, Izhar
   3. Ayuketang Ayuk, Francis
   4. Schilling, Georgia
   5. Atanackovic, Djordje
   6. Zeller, Wolfgang
   7. Yerushalmi, Ronit

   2010 - Forschungsinformationssystem des UKE
3. Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis.

   1. Marx, Andreas
   2. Zielinski, Margarete
   3. Kowitz, Charlotte-Marie
   4. Dancau, Ana Maria
   5. Thieltges, Sabrina
   6. Simon, Ronald
   7. Choschzick, Matthias

   2010 - Forschungsinformationssystem des UKE
4. Autoantibodies against tumor-related antigens: incidence and biologic significance.

   1. Kobold, Sebastian
   2. Luetkens, Tim
   3. Cao, Yanran
   4. Bokemeyer, Carsten
   5. Atanackovic, Djordje

   2010 - Forschungsinformationssystem des UKE
5. Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma.

   1. Pabst, Caroline
   2. Zustin, Jozef
   3. Jacobsen, Frank
   4. Luetkens, Tim
   5. Kröger, Nicolaus
   6. Schilling, Georgia
   7. Bokemeyer, Carsten

   2010 - Forschungsinformationssystem des UKE
6. Prognostic and diagnostic value of spontaneous tumor-related antibodies.

   1. Kobold, Sebastian
   2. Luetkens, Tim
   3. Cao, Yanran
   4. Bokemeyer, Carsten
   5. Atanackovic, Djordje

   2010 - Forschungsinformationssystem des UKE - frei zugänglich
7. Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites?

   1. Kobold, Sebastian
   2. Hegewisch-Becker, Susanna
   3. Oechsle, Karin
   4. Jordan, Karin
   5. Bokemeyer, Carsten
   6. Atanackovic, Djordje

   2009 - Forschungsinformationssystem des UKE
8. Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells.

   1. Atanackovic, Djordje
   2. Hildebrandt, York
   3. Jadczak, Adam
   4. Cao, Yanran
   5. Luetkens, Tim
   6. Meyer, Sabrina
   7. Kobold, Sebastian

   2009 - Forschungsinformationssystem des UKE - frei zugänglich
9. Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.

   1. Atanackovic, Djordje
   2. Luetkens, Tim
   3. Hildebrandt, York
   4. Arfsten, Julia
   5. Bartels, Katrin
   6. Horn, Christiane
   7. Stahl, Tanja

   2009 - Forschungsinformationssystem des UKE
10. Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.

    1. Lioznov, Michael
    2. El-Cheikh, J
    3. Hoffmann, Friedericke
    4. Hildebrandt, York
    5. Ayuketang Ayuk, Francis
    6. Wolschke, Christine
    7. Atanackovic, Djordje

    2009 - Forschungsinformationssystem des UKE
11. Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.

    1. Kröger, Nicolaus
    2. Badbaran, Anita
    3. Lioznov, Michael
    4. Schwartz, Sabine
    5. Zeschke, Silke
    6. Hildebrandt, York
    7. Ayuketang Ayuk, Francis

    2009 - Forschungsinformationssystem des UKE
12. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.

    1. Atanackovic, Djordje
    2. Cao, Yanran
    3. Luetkens, Tim
    4. Panse, Jens
    5. Faltz, Christiane
    6. Arfsten, Julia
    7. Bartels, Katrin

    2008 - Forschungsinformationssystem des UKE - frei zugänglich
13. Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming.

    1. Atanackovic, Djordje
    2. Altorki, Nasser K
    3. Cao, Yanran
    4. Ritter, Erika
    5. Ferrara, Cathy A
    6. Ritter, Gerd
    7. Hoffman, Eric W

    2008 - Forschungsinformationssystem des UKE
14. The local cytokine and chemokine milieu within malignant effusions.

    1. Atanackovic, Djordje
    2. Cao, Yanran
    3. Kim, Ji-Won
    4. Brandl, Stephan
    5. Thoem, Ina
    6. Faltz, Christiane
    7. Hildebrandt, York

    2008 - Forschungsinformationssystem des UKE
15. Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.

    1. Ayuketang Ayuk, Francis
    2. Perez-Simon, José A
    3. Shimoni, Avichai
    4. Sureda, Anna
    5. Zabelina, Tatjana
    6. Schwerdtfeger, Rainer
    7. Martino, Rodrigo

    2008 - Forschungsinformationssystem des UKE - frei zugänglich
16. Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.

    1. Atanackovic, Djordje
    2. Arfsten, Julia
    3. Cao, Yanran
    4. Gnjatic, Sacha
    5. Schnieders, Frank
    6. Bartels, Katrin
    7. Schilling, Georgia

    2007 - Forschungsinformationssystem des UKE
17. Patients with solid tumors treated with high-temperature whole body hyperthermia show a redistribution of naive/memory T-cell subtypes.

    1. Atanackovic, Djordje
    2. Pollok, Kristina
    3. Faltz, Christiane
    4. Boeters, Ina
    5. Jung, Roman
    6. Nierhaus, Axel
    7. Braumann, Klaus-Michael

    2006 - Forschungsinformationssystem des UKE
18. Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinoma.

    1. Atanackovic, Djordje
    2. Blum, Inga
    3. Cao, Yanran
    4. Wenzel, Sören
    5. Bartels, Katrin
    6. Faltz, Christiane
    7. Hossfeld, Dieter Kurt

    2006 - Forschungsinformationssystem des UKE
19. Bortezomib after dose-reduced allogeneic stem cell transplantation for multiple myeloma to enhance or maintain remission status.

    1. Kröger, Nicolaus
    2. Zabelina, Tatjana
    3. Ayuketang Ayuk, Francis
    4. Atanackovic, Djordje
    5. Schieder, Heike
    6. Renges, Helmut
    7. Zander, Axel R.

    2006 - Forschungsinformationssystem des UKE
20. Peripheral T cells of patients with B cell non-Hodgkin's lymphoma show a shift in their memory status.

    1. Atanackovic, Djordje
    2. Panse, Jens
    3. Schafhausen, Philippe
    4. Faltz, Christiane
    5. Bartels, Katrin
    6. Boeters, Ina
    7. Hossfeld, Dieter Kurt

    2005 - Forschungsinformationssystem des UKE